Micro Emerging Active

MoonLake Immunotherapeutics price target raised on FDA progress

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
2
Sources
2

Sentiment Timeline

Event Timeline

Jun 25, 2026
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday Bearish
Jun 04, 2026
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on … Neutral

Timeline

Last UpdatedJun 04, 2026